Silverarc Capital Management »

Gossamer Bio shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Gossamer Bio (GOSS) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Gossamer Bio

Tip: Access up to 7 years of quarterly data

All positions including Gossamer Bio held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gossamer Bio by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $5.1M 6.1M 0.83
2022-12-31 $217k 100k 2.17

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Gossamer Bio

NEA Management Company
Artal Group
Vanguard Group
EcoR1 Capital
Octagon Capital Advisors
Arch Venture Corp
Citadel Advisors
Samsara BioCapital
Palo Alto Investors
Madison Avenue Partners
Hillhouse Capital Advisors
Millennium Management
Deutsche Bank Aktiengesellschaft
T. Rowe Price Associates
Monashee Investment Management

View all funds holding Gossamer Bio